TY - JOUR
T1 - Addressing Determinants of Immunization Inequities Requires Objective Tools to Devise Local Solutions
AU - Datta, Siddhartha Sankar
AU - Martinón-Torres, Federico
AU - Berdzuli, Nino
AU - Cakmak, Niyazi
AU - Edelstein, Michael
AU - Cottrell, Simon
AU - Muscat, Mark
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/4/6
Y1 - 2023/4/6
N2 - Universal immunization substantially reduces morbidity and mortality from vaccine-preventable diseases. In recent years, routine immunization coverage has varied considerably among countries across the WHO European Region, and among different populations and districts within countries. It has even declined in some countries. Sub-optimal immunization coverage contributes to accumulations of susceptible individuals and can lead to outbreaks of vaccine-preventable diseases. The European Immunization Agenda 2030 (EIA2030) seeks to build better health in the WHO European Region by ensuring equity in immunization and supporting immunization stakeholders in devising local solutions to local challenges. The factors that influence routine immunization uptake are context specific and multifactorial; addressing immunization inequities will require overcoming or removing barriers to vaccination for underserved individuals or populations. Local level immunization stakeholders must first identify the underlying causes of inequities, and based on this information, tailor resources, or service provision to the local context, as per the organization and characteristics of the health care system in their countries. To do this, in addition to using the tools already available to broadly identify immunization inequities at the national and regional levels, they will need new pragmatic guidance and tools to address the identified local challenges. It is time to develop the necessary guidance and tools and support immunization stakeholders at all levels, especially those at the subnational or local health centre levels, to make the vision of EIA2030 a reality.
AB - Universal immunization substantially reduces morbidity and mortality from vaccine-preventable diseases. In recent years, routine immunization coverage has varied considerably among countries across the WHO European Region, and among different populations and districts within countries. It has even declined in some countries. Sub-optimal immunization coverage contributes to accumulations of susceptible individuals and can lead to outbreaks of vaccine-preventable diseases. The European Immunization Agenda 2030 (EIA2030) seeks to build better health in the WHO European Region by ensuring equity in immunization and supporting immunization stakeholders in devising local solutions to local challenges. The factors that influence routine immunization uptake are context specific and multifactorial; addressing immunization inequities will require overcoming or removing barriers to vaccination for underserved individuals or populations. Local level immunization stakeholders must first identify the underlying causes of inequities, and based on this information, tailor resources, or service provision to the local context, as per the organization and characteristics of the health care system in their countries. To do this, in addition to using the tools already available to broadly identify immunization inequities at the national and regional levels, they will need new pragmatic guidance and tools to address the identified local challenges. It is time to develop the necessary guidance and tools and support immunization stakeholders at all levels, especially those at the subnational or local health centre levels, to make the vision of EIA2030 a reality.
KW - European Immunization Agenda 2030
KW - immunization
KW - inequities
KW - local determinants
KW - operational guidance
KW - pragmatic
UR - http://www.scopus.com/inward/record.url?scp=85153706705&partnerID=8YFLogxK
U2 - 10.3390/vaccines11040811
DO - 10.3390/vaccines11040811
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
C2 - 37112723
AN - SCOPUS:85153706705
SN - 2076-393X
VL - 11
JO - Vaccines
JF - Vaccines
IS - 4
M1 - 811
ER -